The curative effect of different dose of calcitriol on uremic hemodialysis patients with second dary hyperparathyroidism
- VernacularTitle:尿毒症透析患者不同剂量钙三醇治疗继发性甲状旁腺功能亢进的疗效观察
- Author:
Huarong CHEN
;
Qing LING
;
Ya LI
- Publication Type:Journal Article
- Keywords:
Uremia;
Hyperparathyroidism,secondary;
Calcitriol
- From:
Chinese Journal of Primary Medicine and Pharmacy
2008;15(6):933-934
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the therapeutic effect of routine dose of calcitriol and large dose impulsion therapy on hemodialysis patients with secondary hyperparathyroidism(SHPT). Methods 48 uremic hemodialysis patients were divided into group A(routine group, n = 22) and group B(control group, n = 21 ). In group A,22 pa-tients were administered with calcitriol for 6 months at the dosage of 0.25～0.5μg/d,adding calcium agents simul-taneously;the patients in group B were not given calcitriol for economic reason. In group C,21 patients were given calcitriol twice a week at the dosage of 2μg/time after hemodialysis for 3 months. Results Comparing to group B,serum PTH,AKP in group A had no significant difference,but serum hypocalcium and hyperphasphate were partly corrected,symptoms of bone pain, muscular convulsion and akin pruriter were improved. Comparing to group A,serum hypocalcium and hyperphasphate in group C were corrected, serum PTH, AKP were significantly decreased( t=2.031,P<0.05;t =3.317,P<0.001),and no hypercalcium oecurred. Conelosion Routine dose of calcitriol can not control uremic-SHirr,while impulsion therapy with lower dose oral calcitriol is effective and safe.
